SCHEMBL579760

SCHEMBL579760

CCOc1ccc(CO)cc1OC

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CALM1 P0DP23 3/20 0.61
NPC1 O15118 1/20 0.57
POLB P06746 1/20 0.57
RAB9A P51151 1/20 0.57
GAA P10253 3/20 0.56
KDM4E B2RXH2 1/20 0.56
MAPT P10636 1/20 0.56
TSHR P16473 1/20 0.56
MAPK1 P28482 1/20 0.54
HTT P42858 2/20 0.54
CA2 P00918 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.49
LMNA P02545 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
ACHE P22303 1/20 0.48
S1PR1 P21453 1/20 0.47
S1PR3 Q99500 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30714383 1.00 CALM1 (0.61) CALM1NPC1POLBRAB9AGAA
SCHEMBL3972900 0.93 L3MBTL1 (0.54) CALM1NPC1POLBRAB9AGAA
SCHEMBL697888 0.90 HTT (0.61) CALM1NPC1POLBRAB9AKDM4E
SCHEMBL175622 0.87 ALDH1A1 (0.52) CALM1NPC1POLBRAB9AGAA
Alcohol SCHEMBL8946306 0.86 CA2 (0.63) NPC1POLBRAB9AKDM4ECA2
SCHEMBL28170408 0.86 CA2 (0.68) NPC1POLBRAB9AKDM4EMAPT
SCHEMBL119395 0.86 CA2 (0.68) NPC1POLBRAB9AKDM4EMAPT
SCHEMBL29997296 0.86 CA2 (0.68) NPC1POLBRAB9AKDM4EMAPT
SCHEMBL5873476 0.86 CALM1 (0.67) CALM1POLBGAAKDM4EMAPT
SCHEMBL579301 0.86 NPC1 (0.55) CALM1NPC1POLBRAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 511 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250313900-A1 COMPOSITIONS AND THERAPEUTIC AGENTS FOR MODULATING INFLAMMATORY RESPONSES ON BOTH TUMOR AND IMMUNE CELLS THE METHODIST HOSPITAL 2025-10-09 US claimed
WO-2023240291-A2 COMPOSITIONS AND THERAPEUTIC AGENTS FOR MODULATING INFLAMMATORY RESPONSES ON BOTH TUMOR AND IMMUNE CELLS THE METHODIST HOSPITAL SYSTEM (US) 2023-12-14 WO claimed
CN-115721567-A Thermal wet tissue and preparation method thereof 芜湖悠派护理用品科技股份有限公司 2023-03-03 CN claimed
CN-113576987-A Massage gel applied to wave instrument and preparation method thereof 广州丽亦健美容美体设备有限公司 2021-11-02 CN claimed
CN-113389055-A Cool or heat-sensitive microcapsule, nonwoven fabric and absorbent article 上海护理佳实业有限公司 2021-09-14 CN claimed
CN-113045388-A Synthetic method of vanillyl alcohol ethyl ether 重庆欣欣向荣精细化工有限公司 2021-06-29 CN claimed
CN-112513162-A Novel compositions for bittering agents UPL有限公司 2021-03-16 CN claimed
CN-111962292-A Spontaneous heating material body and spontaneous heating activated carbon non-woven fabric hair cap 上海创始实业(集团)有限公司 2020-11-20 CN claimed
CN-106458861-B Cyclopropanecarboxamides having cooling properties 宝洁公司 2020-05-19 CN claimed
CN-104887581-B A kind of oral care composition and preparation method thereof 云南天美天康生物科技有限公司 2018-02-23 CN claimed
US-6319310-B1 FOR ACOUSTIC INK JET PRINTING; TRANSPARENCY, GLOSS, CREASE RESISTANCE XEROX CORPORATION 2001-11-20 US claimed
US-6306429-B1 THROAT DROPS SUITABLE FOR RELIEF OF COUGH AND COLD SYMPTOMS THE PROCTER & GAMBLE COMPANY 2001-10-23 US claimed
EP-0674232-B1 Recording sheets XEROX CORP (US) 2000-05-31 EP claimed
EP-0977554-A1 CONFECTIONERY COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2000-02-09 EP claimed
EP-0977553-A1 THROAT SOOTHING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2000-02-09 EP claimed
WO-1998047482-A1 THROAT SOOTHING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-10-29 WO claimed
WO-1998047483-A1 CONFECTIONERY COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-10-29 WO claimed
EP-0837862-A1 WARMING COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 1998-04-29 EP claimed
WO-1997002273-A1 WARMING COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 1997-01-23 WO claimed
EP-0674232-A2 Recording sheets XEROX CORPORATION (US) 1995-09-27 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250313900-A1 COMPOSITIONS AND THERAPEUTIC AGENTS FOR MODULATING INFLAMMATORY RESPONSES ON BOTH TUMOR AND IMMUNE CELLS MIF, CCL2, MPEG1 CALM1 1953/4885NPC1 2249/4885POLB 3455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.